Serodiversity of opsonic antibodies against Enterococcus faecalis -glycans of the cell wall revisited

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Theilacker, Christian ^a   Kaczyński, Zbigniew ^b   Kropec, Andrea ^a   Sava, Irina ^a   Ye, Libin ^a   Bychowska, Anna ^b   Holst, Otto ^c   Huebner, Johannes ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF GDA SK   (Poland)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; BACTERIUM ANTIBODY; DIHETEROGLYCAN ANTIBODY; GLYCAN; LACTIC ACID; LIPOTEICHOIC ACID ANTIBODY; OPSONIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYSACCHARIDE; TEICHOIC ACID;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; BACTEREMIA; BACTERIAL CELL WALL; BACTERIAL COUNT; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FEMALE; GENE LOCUS; MOUSE; NONHUMAN; OPSONIZATION; PASSIVE IMMUNIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SYNTHESIS; PROTEIN TARGETING; SEROTYPE; ANIMAL; ANTIBODY SPECIFICITY; BACTERIAL MEMBRANE; BLOOD; CELL WALL; CHEMISTRY; CROSS REACTION; DISEASE MODEL; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHAGOCYTOSIS; RABBIT; STRUCTURAL HOMOLOGY; VACCINATION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; MUS; ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTEREMIA; BACTERIAL CAPSULES; CELL WALL; CROSS REACTIONS; DISEASE MODELS, ANIMAL; ENTEROCOCCUS FAECALIS; GENETIC LOCI; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; OPSONIN PROTEINS; PHAGOCYTOSIS; POLYSACCHARIDES; RABBITS; STRUCTURAL HOMOLOGY, PROTEIN; TEICHOIC ACIDS; VACCINATION;

EID: 79952790266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017839     Document Type: Article

References (48)

1. Ruoff KL, Bisno AL, (2010) Classification of Streptococci. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7. ed Philadelphia Churchill Livingstone pp. 2591-2592.
2. Wicken AJ, Elliott SD, Baddiley J, (1963) The identity of streptococcal group D antigen with teichoic acid. J Gen Microbiol 31: 231-239.
3. Theilacker C, Kaczynski Z, Kropec A, Fabretti F, Sange T, et al. (2006) Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect Immun 74: 5703-5712.
4. Hufnagel M, Hancock LE, Koch S, Theilacker C, Gilmore MS, et al. (2004) Serological and genetic diversity of capsular polysaccharides in Enterococcus faecalis. J Clin Microbiol 42: 2548-2557.
5. Pazur JH, Cepure A, Kane JA, Hellerquist CG, (1973) Glycans from streptococcal cell walls. The molecular structure of an antigenic diheteroglycan of glucose and galactose from Streptococcus faecalis. J Biol Chem 248: 279-284.
6. Pazur JH, Anderson JS, Karakawa WW, (1971) Glycans from streptococcal cell walls. Immunological and chemical properties of a new diheteroglycan from Streptococcus faecalis. J Biol Chem 246: 1793-1798.
7. Bleiweis AS, Krause RM, (1965) The Cell Walls Of Group D Streptococci. I. The Immunochemistry Of The Type 1 Carbohydrate. J Exp Med 122: 237-249.
8. Bleiweis AS, Young FE, Krause RM, (1967) Cell walls of group D streptococci. II. Chemical studies on the type 1 antigen purified from the autolytic digest of cell walls. J Bacteriol 94: 1381-1387.
9. Elliott SD, (1960) Type and group polysaccharides of group D streptococci. J Exp Med 111: 621-630.
10. Hsu CT, Ganong AL, Reinap B, Mourelatos Z, Huebner J, et al. (2006) Immunochemical characterization of polysaccharide antigens from six clinical strains of Enterococci. BMC Microbiol 6: 62.
11. Teng F, Singh K, Bourgogne A, Zeng J, Murray B, (2009) Further Characterization of the epa Gene Cluster and Epa Polysaccharides of Enterococcus faecalis. Infect Immun.
12. Hancock LE, Gilmore MS, (2002) The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A 99: 1574-1579.
13. Hancock LE, Shepard BD, Gilmore MS, (2003) Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant. J Bacteriol 185: 4393-4401.
14. Thurlow LR, Thomas VC, Fleming SD, Hancock LE, (2009) Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion. Infect Immun 77: 5551-5557.
15. Thurlow LR, Thomas VC, Hancock LE, (2009) Capsular polysaccharide production in Enterococcus faecalis and contribution of CpsF to capsule serospecificity. J Bacteriol 191: 6203-6210.
16. Xu Y, Murray BE, Weinstock GM, (1998) A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF. Infect Immun 66: 4313-4323.
17. Xu Y, Singh KV, Qin X, Murray BE, Weinstock GM, (2000) Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect Immun 68: 815-823.
18. Teng F, Jacques-Palaz KD, Weinstock GM, Murray BE, (2002) Evidence that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in Enterococcus faecalis and influences resistance to phagocytic killing of E. faecalis. Infect Immun 70: 2010-2015.
19. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 29: 996-1011.
20. Vincent JL, Norrenberg M, (2009) Intensive care unit-acquired weakness: framing the topic. Crit Care Med 37: S296-298.
21. McBride SM, Fischetti VA, Leblanc DJ, Moellering RC Jr, Gilmore MS, (2007) Genetic diversity among Enterococcus faecalis. PLoS ONE 2: e582.
22. Huebner J, Wang Y, Krueger WA, Madoff LC, Martirosian G, et al. (1999) Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun 67: 1213-1219.
23. Knirel YA, Paramonov NA, Vinogradov EV, Kochetkov NK, Sidorczyk Z, et al. (1994) 2-Acetamido-4-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose: a new natural isomer of N-acetylmuramic acid from the O-specific polysaccharide of Proteus penneri 35. Carbohydr Res 259.
24. Knirel YA, Paramonov NA, Vinogradov EV, Shashkov AS, Kochetkov NK, et al. (1992) Structure of the O-specific polysaccharide of Proteus penneri 62 containing 2-acetamido-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose (N-acetylisomuramic acid). Carbohydr Res 235: C19-23.
25. Beynon LM, Richards JC, Perry MB, (1997) Identification of the common antigenic determinant shared by Streptococcus pneumoniae serotypes 35A and 20 capsular polysaccharides-structural analysis of the Streptococcus pneumoniae serotype 35A capsular polysaccharide. Eur J Biochem 250: 163-167.
26. Maekawa S, Yoshioka M, Kumamoto Y, (1992) Proposal of a new scheme for the serological typing of Enterococcus faecalis strains. Microbiol Immunol 36: 671-681.
27. Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, et al. (2003) Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun 71: 3875-3884.
28. McNeely TB, Staub JM, Rusk CM, Blum MJ, Donnelly JJ, (1998) Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques. Infect Immun 66: 3705-3710.
29. Stranger-Jones YK, Bae T, Schneewind O, (2006) Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A 103: 16942-16947.
30. Maira-Litran T, Kropec A, Goldmann DA, Pier GB, (2005) Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 73: 6752-6762.
31. Lee JC, Park JS, Shepherd SE, Carey V, Fattom A, (1997) Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 65: 4146-4151.
32. Burnie JP, Matthews RC, Carter T, Beaulieu E, Donohoe M, et al. (2000) Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun 68: 3200-3209.
33. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA, (2005) Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41: 327-333.
34. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, et al. (2006) Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 42: 195-203.
35. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, et al. (2001) Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med 135: 484-492.
36. Lowry OH, Roberts NR, Leiner KY, Wu ML, Farr L, (1954) The quantative histochemistry of the brain. I Chemical methods. J Biol Chem 207: 1-17.
37. Dubios M, Gilles KA, Hamilton JK, Reabers PA, Smith F, (1956) Colorimetric method for the determination of sugars and related substances. Anal Chem 28: 350-356.
38. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Chem 28: 350-356.
39. Segrest JP, Jackson RL, (1972) Molecular weight determination of glycoproteins by polyacrylamide gel electrophoresis in sodium dodecyl sulfate. Methods Enzymol 28: 54-61.
40. Leontein K, Lindberg B, Lonngren J, (1978) Assignment of absolute configuration of neutral sugar monosaccharides by high-resolution capillary g.l.c. Carb Res 62: 359-362.
41. Haseley SR, Holst O, Brade H, (1997) Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter haemolyticus strain ATCC 17906. Eur J Biochem 244: 761-766.
42. Theilacker C, Sanchez-Carballo P, Toma I, Fabretti F, Sava I, et al. (2009) Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis. Mol Microbiol 71: 1055-1069.
43. Hufnagel M, Koch S, Creti R, Baldassarri L, Huebner J, (2004) A putative sugar-binding transcriptional regulator in a novel gene locus in Enterococcus faecalis contributes to production of biofilm and prolonged bacteremia in mice. J Infect Dis 189: 420-430.
44. Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB, (2000) Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and-resistant enterococci. Infect Immun 68: 4631-4636.
45. Gold OG, Jordan HV, van Houte J, (1975) The prevalence of enterococci in the human mouth and their pathogenicity in animal models. Arch Oral Biol 20: 473-477.
46. Rhinehart E, Smith NE, Wennersten C, Gorss E, Freeman J, et al. (1990) Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 323: 1814-1818.
47. Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, et al. (1989) In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 33: 1588-1591.
48. Jacob AE, Hobbs SJ, (1974) Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J Bacteriol 117: 360-372.